Literature DB >> 16042658

Review article: quality-of-life issues in gastro-oesophageal reflux disease.

E M M Quigley1, A P S Hungin.   

Abstract

The purpose of this review is to explore issues relating to quality of life in gastro-oesophageal reflux disease, examining the range of generic and disease-specific instruments available, their applicability and limitations and to overview the effect of gastro-oesophageal reflux disease on quality of life. Whereas instruments have been developed to assist researchers, there is a paucity of reliable instruments for pragmatic use in the clinical setting. The situation is complicated because there is not necessarily a direct correlation between endoscopic findings and symptom severity and non-erosive reflux disease is now recognized as an important manifestation of gastro-oesophageal reflux disease. However, quality-of-life instruments are useful in evaluating the impact of therapies and interventions, although these are limited, particularly in surgical interventions. Impaired quality of life now forms part of a definition of gastro-oesophageal reflux disease, the impact of which goes beyond the symptoms alone. While the symptoms themselves have a negative effect on sufferers' lives, there are secondary effects caused by impaired physical, emotional and social functioning on productivity. Non-gastrointestinal problems caused by gastro-oesophageal reflux disease also impair quality of life. There is an ongoing need to develop instruments which truly measure the impact of gastro-oesophageal reflux disease and which are readily interpretable to the individual patient and clinician.

Entities:  

Mesh:

Year:  2005        PMID: 16042658     DOI: 10.1111/j.1365-2036.2005.02608.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  11 in total

1.  Impact of adult spinal deformity corrective surgery in patients with the symptoms of gastroesophageal reflux disease: a 5-year follow-up report.

Authors:  Tomohiko Hasegawa; Hiroki Ushirozako; Yu Yamato; Daisuke Togawa; Go Yoshida; Sho Kobayashi; Tatsuya Yasuda; Tomohiro Banno; Hideyuki Arima; Shin Oe; Tomohiro Yamada; Koichiro Ide; Yuh Watanabe; Yukihiro Matsuyama
Journal:  Eur Spine J       Date:  2020-01-25       Impact factor: 3.134

2.  Acid-suppressive effect of rabeprazole 5 mg and 10 mg once daily by 24-hour esophageal pH monitoring in patients with non-erosive reflux disease in Japan: a multicenter, randomized, parallel-group, double-blind pharmacodynamic study.

Authors:  Kiyoshi Ashida; Yoshikazu Kinoshita; Michio Hongo
Journal:  Dig Dis Sci       Date:  2011-02-08       Impact factor: 3.199

3.  Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology.

Authors:  Shobna J Bhatia; Govind K Makharia; Philip Abraham; Naresh Bhat; Ajay Kumar; D Nageshwar Reddy; Uday C Ghoshal; Vineet Ahuja; G Venkat Rao; Krishnadas Devadas; Amit K Dutta; Abhinav Jain; Saurabh Kedia; Rohit Dama; Rakesh Kalapala; Jose Filipe Alvares; Sunil Dadhich; Vinod Kumar Dixit; Mahesh Kumar Goenka; B D Goswami; Sanjeev K Issar; Venkatakrishnan Leelakrishnan; Mohandas K Mallath; Philip Mathew; Praveen Mathew; Subhashchandra Nandwani; Cannanore Ganesh Pai; Lorance Peter; A V Siva Prasad; Devinder Singh; Jaswinder Singh Sodhi; Randhir Sud; Jayanthi Venkataraman; Vandana Midha; Amol Bapaye; Usha Dutta; Ajay K Jain; Rakesh Kochhar; Amarender S Puri; Shivram Prasad Singh; Lalit Shimpi; Ajit Sood; Rajkumar T Wadhwa
Journal:  Indian J Gastroenterol       Date:  2019-12-05

4.  Treatment of non-erosive reflux disease with a proton pump inhibitor in Chinese patients: a randomized controlled trial.

Authors:  Victoria P Y Tan; Wai M Wong; Ting K Cheung; Kam C Lai; Ivan F N Hung; Pierre Chan; Roberta Pang; Benjamin C Y Wong
Journal:  J Gastroenterol       Date:  2011-05-03       Impact factor: 7.527

5.  Quality of life and patient satisfaction after laparoscopic antireflux surgery using the QOLARS questionnaire.

Authors:  Zs Zéman; T Tihanyi
Journal:  Surg Endosc       Date:  2007-02-09       Impact factor: 4.584

6.  Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study.

Authors:  Victoria P Y Tan; Tin K Cheung; Wai M Wong; Roberta Pang; Benjamin C Y Wong
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

7.  Lack of correlation between a self-administered subjective GERD questionnaire and pathologic GERD diagnosed by 24-h esophageal pH monitoring.

Authors:  Kevin Chan; Geoffrey Liu; Linda Miller; Clement Ma; Wei Xu; Christopher M Schlachta; Gail Darling
Journal:  J Gastrointest Surg       Date:  2010-03       Impact factor: 3.452

Review 8.  Helicobacter pylori Infection in Gastroesophageal Reflux Disease in the Asian Countries.

Authors:  Su Jin Hong; Sang Woo Kim
Journal:  Gastroenterol Res Pract       Date:  2015-01-06       Impact factor: 2.260

9.  Atypical symptoms are related to typical symptoms rather than histologic and endoscopic esophagitis.

Authors:  Jung Hwan Oh
Journal:  J Neurogastroenterol Motil       Date:  2012-07-10       Impact factor: 4.924

10.  Prevalence of cytotoxin-associated genes of Helicobacter pylori among Iranian GERD patients.

Authors:  Aref Shavalipour; Habib Malekpour; Hossein Dabiri; Hossein Kazemian; Homayon Zojaji; Mahboube Bahroudi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.